Anti-Cat CD122/IL2RB Polyclonal Antibody from ProteoGenix; catalogue ARO-A22103; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Anti-Cat CD122/IL2RB Polyclonal Antibody
The Anti-Cat CD122/IL2RB Polyclonal Antibody is a powerful tool for studying the immune system in cats. It specifically targets the CD122/IL2RB protein, which is a subunit of the interleukin-2 receptor. This protein plays a critical role in the regulation of immune responses and is essential for T cell proliferation and survival.
This antibody is highly specific and can be used for a variety of applications in biotechnology and immunology research. It is particularly useful for studying the role of CD122/IL2RB in immune-mediated diseases and for identifying potential therapeutic targets.
The Anti-Cat CD122/IL2RB Polyclonal Antibody has been successfully used in various experimental settings. It has been shown to effectively block CD122/IL2RB signaling, leading to a decrease in T cell proliferation. This makes it an ideal tool for investigating the mechanisms of immune tolerance and autoimmunity.
In addition, this antibody has been used in flow cytometry and western blotting experiments to detect and quantify CD122/IL2RB expression levels in different cell types and tissues. Its high sensitivity and specificity make it a valuable tool for characterizing the immune cell population in both healthy and diseased animals.
This antibody has been specifically designed for use in cats, making it a valuable addition to any feline immunology research project. Its target protein, CD122/IL2RB, is a key player in the cat’s immune system, making this antibody an essential tool for understanding and manipulating immune responses in these animals.
Structure and
The CD122/IL2RB protein is a crucial component of the interleukin-2 receptor and plays a critical role in regulating immune responses in cats.
This highly specific antibody is ideal for studying the role of CD122/IL2RB in immune-mediated diseases and identifying potential therapeutic targets.
The Anti-Cat CD122/IL2RB Polyclonal Antibody has been successfully used in blocking CD122/IL2RB signaling, flow cytometry, and western blotting experiments to study immune tolerance and autoimmunity in cats.
ProteoGenix catalogue number ARO-A22103. For research use only.
Target: interleukin-2 receptor subunit beta isoform X2; IL2RB; Clonality: Polyclonal Antibody; Applications: ELISA, IHC.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| interleukin-2 receptor subunit beta isoform X2; IL2RB |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
